160 related articles for article (PubMed ID: 3088612)
1. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
Bekemeier H; Hirschelmann R
Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
[TBL] [Abstract][Full Text] [Related]
2. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
[TBL] [Abstract][Full Text] [Related]
3. On steroid-saving drug combinations in carrageenin paw edema and adjuvant arthritis.
Bekemeier H; Hirschelmann R
Arzneimittelforschung; 1986 Oct; 36(10):1521-4. PubMed ID: 3101708
[TBL] [Abstract][Full Text] [Related]
4. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor].
Tajima M; Maruyama S; Ichikawa M; Kim T; Arai T; Sato S
Josai Shika Daigaku Kiyo; 1984; 13(1):60-7. PubMed ID: 6441611
[No Abstract] [Full Text] [Related]
6. [Enzyme inhibitors and receptor antagonists in the arachidonic cascade].
Arai Y; Kawamura M
Nihon Rinsho; 1990 Jun; 48(6):1120-8. PubMed ID: 2166837
[No Abstract] [Full Text] [Related]
7. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins.
Parente L; Di Rosea M; Flower RJ; Ghiara P; Meli R; Persico P; Salmon JA; Wood JN
Eur J Pharmacol; 1984 Mar; 99(2-3):233-9. PubMed ID: 6428924
[TBL] [Abstract][Full Text] [Related]
8. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
Cirino G; Peers SH; Flower RJ; Browning JL; Pepinsky RB
Proc Natl Acad Sci U S A; 1989 May; 86(9):3428-32. PubMed ID: 2470103
[TBL] [Abstract][Full Text] [Related]
10. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
11. Effects of hypolaetin-8-glucoside and related flavonoids on soybean lipoxygenase and snake venom phospholipase A2.
Alcaraz MJ; Hoult JR
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):4-12. PubMed ID: 3938206
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
Nakadate T; Yamamoto S; Ishii M; Kato R
Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase A2 activity in carrageenin-induced inflammatory tissue of rats.
Ohuchi K; Watanabe M; Numajiri N; Tsurufuji S
Biochem Pharmacol; 1982 Sep; 31(18):2993-8. PubMed ID: 6814450
[TBL] [Abstract][Full Text] [Related]
14. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
[No Abstract] [Full Text] [Related]
16. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
Cass WA; Larson G; Fitzpatrick FA; Zahniser NR
J Pharmacol Exp Ther; 1991 Jun; 257(3):990-6. PubMed ID: 1828506
[TBL] [Abstract][Full Text] [Related]
17. Effect of flavonoids on arachidonic acid metabolism.
Welton AF; Tobias LD; Fiedler-Nagy C; Anderson W; Hope W; Meyers K; Coffey JW
Prog Clin Biol Res; 1986; 213():231-42. PubMed ID: 3086892
[No Abstract] [Full Text] [Related]
18. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
Mayer AM
Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
[TBL] [Abstract][Full Text] [Related]
19. Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion.
Kojima I; Kojima K; Rasmussen H
Endocrinology; 1985 Sep; 117(3):1057-66. PubMed ID: 3926464
[TBL] [Abstract][Full Text] [Related]
20. Modulation of skin tumor promotion by inhibitors of arachidonic acid metabolism.
Fischer SM; Mills GD; Slaga TJ
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():309-12. PubMed ID: 6221608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
